Connect with us

Emerging Markets

Industrial Nanotech Inc. (OTCMKTS: INTK) Running Northbound as Co Goes Pink Current & Readies Launch of its New Smart Coating Product Line; TalkingPaint

Published

on

Industrial Nanotech Inc. (OTCMKTS: INTK) is moving higher steadily as the Company makes significant progress. 2021 has been a big year for INTK which has been moving higher all year recently taking out 52-week highs and entering a new blue-sky breakout. INTK has emerged in recent weeks as an investor favorite and is starting to get noticed by some big players. The stock has liquidity, momentum and a fast-growing shareholder base bidding the stock higher. 

INTK went “pink current” earlier this year and management has stated its intention to up list to a senior exchange. The Company has little debt on the books and management continues to affirm there will be no reverse split. INTK expects sales of its new product, TalkingPaint, its new smart coating product line, to begin by the end of Q1 2022 at which point the Company plans to establish a manufacturing facility in South Carolina for its new self-reporting insulation for pipes. INTK expects sales of EnergyProtect to Italy under the Superbonus 110 program to begin Q1 2022 and sales in the EU under the European Union sponsored Energy Performance of Buildings Directive to begin Q1 2022. 

Industrial Nanotech Inc. (OTCMKTS: INTK) operating out of Naples, Florida funds & participates in research with the world’s brightest scientists and leading laboratories. The Company produces materials that work for you… increasing productivity and efficiency. It’s not just talk and it’s not just theory… it’s amazing technologies. Industrial Nanotech, Inc. was incorporated in 2004 and specializes in developing sustainable nanotechnology-based solutions that are easy-to-use and designed to save energy, protect assets, and reduce carbon footprints. INTK technologies help the world save energy, protect assets, and live and work more sustainably. The Company’s products are sold through a global network of distributors. 

The Company develops, manufactures, and markets industrial grade insulation products utilizing nanotechnology in the United States and internationally. Its products include Nansulate Translucent PT and Nansulate Translucent High Heat, which are protective thermal insulation and corrosion prevention coatings; EPX4 for total asset protection; Nansulate Translucent GP – NSF, an insulation and mold resistant coating for food sensitive environments; Home Protect ClearCoat, a protective insulation and mold prevention coating; Nansulate Energy Protect, an industrial and commercial insulation and protective coating; Nansulate Crystal Roof Coating for clear energy saving and mold resistant protection; Intelligent Shield, which offers cool color choices for exterior painting projects; Nansulate LDX Clear Lead Encapsulation Coating for lead abatement; NANOBOOST , an automotive coating; Bee Protect that is formulated to protect bees in their hives; and Nansulate Insulation for solar panels, solar water heaters, and solar thermal equipment. INTK expects sales of its new product, TalkingPaint, its new smart coating product line, to begin by the end of Q1 2022 at which point the Company plans to establish a manufacturing facility in South Carolina for its new self-reporting insulation for pipes.  According to INTK website the Company’s customers include or have included Walmart, Nestle, Caterpillar, Royal Caribbean, Yamaha, Conagra, Citgo and Nasa to name a few. 

INTK started moving in September after the Company reported it was going pink current which has now happened. CEO/CTO, Stuart Burchill stated at the time: “We are also beginning the process of having our financials for 2020 and 2021 audited by an independent PCAOB auditor so that we can finish in the first months of 2022 and make application to a higher listing status. Smaller sales, LeadX and small projects, were not severely impacted by the pandemic. Larger sales were dramatically affected. Larger projects require us to visit the plant and demonstrate the products and, after the sale, they require outside contractors to be allowed on site. Our large order customers had a complete ban on outsiders coming into the factories or restricted it to only the most essential outside personnel. Now we are beginning to see those restrictions lifted and we are very optimist about the upcoming quarters and years.” 

To Find out the inside Scoop on INTK Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

INTK

In a recent update Mr. Burchill stated: 

1) The Company expects sales of EnergyProtect to Italy under the Superbonus 110 program to begin Q1 2022. The Company’s distributor in Italy anticipates that sales could grow to nineteen million dollars US annually by the end of 2022. 

2) The Company expects sales of EnergyProtect for the EU under the European Union sponsored Energy Performance of Buildings Directive to begin Q1 2022. The Company’s distributors in the EU anticipate that sales could grow to forty five million dollars US annually by the end of 2022. 

3) The Company expects sales of their new product, TalkingPaint, their new smart coating product line, to begin by the end of Q1 2022. The Company intends to capture 15% of the potential market by the end of 2022, which could produce sales of thirty million dollars US annually. 

4) The Company plans to establish a manufacturing facility in South Carolina for their new self reporting insulation for pipes. The Company anticipates sales to begin in Q2 2022. 

5) The Company is preparing for up listing to more senior exchanges, including having PCAOB audited financials for 2021 and 2020. The Company confirms that there is no plan for a reverse split while the Company remains on OTCMarkets. If Company’s uplists to either NASDAQ or NYSE the Company would rely on advice of legal counsel and financial advisors regarding a possible capital structure revision. Timeline for application to up list to NYSE or NASDAQ is 2023. The Company will be focused primarily on revenue 24/7 during 2022. 

On December 27 INTK reported it has appointed DMA | Digital Marketing Agency as its agency of record following an extensive review that started four months ago. DMA will create a dedicated team for Industrial Nanotech and will guide brand strategy, creative, and with digital marketing initiatives for the company’s three brands (Syneffex, Anaconda, Talking Paint) as the marketer looks to capitalize on businesses’ newfound appreciation for energy saving initiatives and innovative solutions to reduce costs after the pandemic.  

Stuart Burchill, CEO of Industrial Nanotech, announced that the Company has signed a two-year multimillion dollar agreement with DMA.  “We were looking for an agency that was data-driven and had a global footprint.  After doing our diligence, we found DMA’s core focus of delivering high quality talent for all our digital marketing initiatives as the difference. We also wanted a partner that shared our excitement for product innovation and opportunity.  We felt there was a real meeting of minds with DMA.  We attended multiple workshops and the way that DMA was able to stand out and hone their creative work until the end was just incredible. We are excited to share this vision with our clients, potential clients, shareholders, and other stakeholders via a webinar on Jan 10, 2022,” 

For more on INTK Subscribe Right Now!

INTK is moving higher steadily as the Company makes significant progress. 2021 has been a big year for INTK which has been moving higher all year recently taking out 52-week highs and entering a new blue-sky breakout. INTK has emerged in recent weeks as an investor favorite and is starting to get noticed by some big players. The stock has liquidity, momentum and a fast-growing shareholder base bidding the stock higher.  INTK went “pink current” earlier this year and management has stated its intention to up list to a senior exchange. The Company has little debt on the books and management continues to affirm there will be no reverse split. INTK expects sales of its new product, TalkingPaint, its new smart coating product line, to begin by the end of Q1 2022 at which point the Company plans to establish a manufacturing facility in South Carolina for its new self-reporting insulation for pipes. INTK expects sales of EnergyProtect to Italy under the Superbonus 110 program to begin Q1 2022 and sales in the EU under the European Union sponsored Energy Performance of Buildings Directive to begin Q1 2022. We will be updating on INTK so make sure you Subscribe to Microcapdaily so you know what’s going on with INTK.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in INTK either long or short and we have not been compensated for this article.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Emerging Markets

Aclarion Inc (NASDAQ: ACON): A Breakthrough Partnership

Published

on

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic.

Aclarion, Inc. (NASDAQ: ACON) shares rocketed 157% Tuesday morning after their commercialization agreement with the London Clinic. The London Clinic is UK’s most renowned independent, private hospital, established 1932 with their Spine Clinic being the first specialist spinal unit based in England back in 1997.

“With a focus on providing the very best healthcare outcomes, The London Clinic is an ideal customer for Aclarion as the company works to deliver the Nociscan solution to physicians and patients around the world,” said John Sutcliffe MD, Neurosurgeon and Founder of London Spine Clinic. “The engagement with Aclarion will allow London Spine Clinic to continue offering the high-quality care our patients have come to expect. Patients need a careful assessment, diagnosis, and understanding of the different treatment options. Aclarion’s innovative Nociscan solution will enable us to objectively assess biomarkers associated with low back pain and enhance the precision of each diagnosis.”

More on Nociscan Technology

Aclarion, Inc.’s Nociscan Technology is an innovative medical solution that aims to revolutionize the diagnosis of disc-related conditions. They leverage biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain.

What’s exciting is its advantages over the current standard of care. It offers a non-invasive approach, ensuring patient comfort and safety. Given it’s non-invasive, that also means 0 pain with 0 radiation (typically associated with traditional discography). The best part is it can seamlessly integrate into standard lumbar MRI protocols, making it a convenient and efficient option for healthcare providers. 

To Discover the Inside Scoop on ACON, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

The procedure takes approximately 25-45 minutes, thoroughly evaluating spinal discs without compromising accuracy. Additionally, Nociscan technology offers significant cost savings, with a list price of $1,450, making it an affordable alternative to traditional discograms. Overall, Aclarion, Inc.’s technological advances represent a significant push forward in disc-related diagnostic techniques, prioritizing patient well-being, convenience, and affordability.

https://twitter.com/TigerLineTrades/status/1663527784143093762?s=20

Nociscan Study

They also recently completed a study that spanned two years and involved 78 patients at a single site. The success rate soared to an impressive 85% for patients whose treatment strategy aligned with the disks identified by Nociscan. This represented a remarkable 22% improvement over patients whose treatment strategy did not consider the insights provided by Nociscan.

Aclarion expressed confidence that the results of the trial demonstrate the potential of Nociscan to assist physicians in successfully treating DLBP. Dr. Matthew Gornet, orthopedic surgeon and lead author of the study, enthusiastically endorsed Nociscan, stating, “The two-year surgical outcomes of the clinical trial provide unequivocal evidence of its effectiveness, particularly with regards to the primary endpoint, the Oswestry Disability Index (ODI). I firmly believe that Nociscan has the potential to revolutionize the standard of care and accurately aid all physicians treating chronic low back pain.”

It is worth noting that although Nociscan was performed on all patients in the study, it was not part of the surgical decision-making process, as highlighted by the company.

Conclusion

The commercial agreement between Aclarion, Inc. and the prestigious London Clinic signifies a significant milestone for both parties, carrying the potential for global recognition, revenue growth, and scalability. By integrating Aclarion’s innovative Nociscan Technology, the London Clinic demonstrates its commitment to delivering cutting-edge healthcare to optimize patient well-being and enhance clinical outcomes. Furthermore, the partnership’s success holds the potential for scaling Nociscan Technology to other institutions and markets, propelling Aclarion, Inc. to become a global leader in non-invasive medical technologies while driving substantial revenue growth.

We will update you on ACON when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by PIRO from Pixabay

Continue Reading

Emerging Markets

Aemetis Inc. (NASDAQ: AMTX) Pioneers Renewable Fuel Market with EPA Approval

Published

on

Aemetis (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the EPA.

Aemetis, Inc. (NASDAQ: AMTX) shares surged 105% this week. The renewable natural gas and renewable fuels company received approval from the U.S. EPA to generate renewable identification numbers (RINs) under the federal Renewable Fuel Standard. They have six dairy biogas digesters up and running, with a seventh one scheduled to start operating in June 2023.

Aemetis plans to generate multiple sources of revenue from its renewable natural gas. They will sell the gas to replace petroleum diesel in transportation, sell California Low Carbon Fuel Standard credits to fuel blenders who need to meet carbon reduction requirements in California, sell the RINs generated under the federal Renewable Fuel Standard, and benefit from production tax credits starting in 2025 under the Inflation Reduction Act.

They have completed constructing and operating six dairy digesters, a biogas pipeline spanning over 40 miles, a central facility to upgrade biogas to renewable natural gas, and a utility pipeline interconnection unit. The renewable natural gas is injected into the utility gas system and stored underground until Aemetis Biogas obtains carbon intensity (CI) pathway approvals from the California Air Resources Board (CARB) to sell credits under the California Low Carbon Fuel Standard.

They have already completed 90 days of renewable natural gas production and data collection required for the CARB approval process. While the final pathway is under review by CARB, Aemetis can use a temporary CI pathway with a value of -150, allowing them to start generating revenue in the third quarter of 2023.

To Discover the Inside Scoop on AMTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Andy Foster, the president of Aemetis Biogas Inc., expressed excitement about the approval of Aemetis Biogas for generating D3 RINs, as it marks a significant milestone towards generating full product revenue. He emphasized that the company’s investments since 2019 have directly reduced greenhouse gas pollution, improved air quality in Central Valley communities, and created jobs. Aemetis is committed to expanding their network of dairy digesters and producing more carbon-negative renewable natural gas to replace petroleum diesel.

The dairy digesters, pipeline project, and biogas-to-RNG facility funding includes grants from the California Department of Food and Agriculture and the California Energy Commission. Aemetis also closed a $25 million long-term financing deal with Greater Commercial Lending last fall, supported by a loan guarantee from the USDA. This project financing has a low fixed interest rate for the first five years and spans over 20 years.

Aemetis has plans to file applications for an additional $100 million of loans from the USDA’s REAP loan program. These funds will support the engineering, permitting, and construction of 31 more dairies. Each loan application will be limited to a maximum of $25 million and carry a 20-year repayment term.

https://twitter.com/Theweedfarmer/status/1658946668052504576?s=20

Where could Aemetis, Inc. (NASDAQ: AMTX) be in 5 years?

The company has an ambitious Five Year Plan to generate substantial revenue and reduce air and carbon pollution. The plan projects $2.0 billion in revenues, $496 million in net income, and $682 million in adjusted EBITDA by 2027, with strong compound annual growth rates. Aemetis aims to expand its operations by producing Renewable Natural Gas (RNG), Sustainable Aviation Fuel (SAF), Renewable Diesel fuel (RD), and other low-carbon products. The plan emphasizes the positive financial impact of the Inflation Reduction Act.

The plan highlights the financial benefits of the Inflation Reduction Act, which enables the transfer of tax credits and incentives related to production, projected to improve net income by $341 million in 2027.

The plan also focuses on revenue growth in all product lines, including expanding the dairy RNG business, constructing a renewable jet/diesel plant, implementing carbon sequestration, and improving energy efficiencies. 

The company has already achieved significant milestones, such as completing biogas pipeline construction, upgrading facilities for biogas-to-RNG production, and progressing in carbon sequestration and renewable jet/diesel plant development. The company has also secured a biodiesel purchase agreement in India and made strides in constructing a solar microgrid and implementing energy-efficient measures.

We will update you on AMTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Leopold Böttcher from Pixabay

Continue Reading

Emerging Markets

GSI Technology, Inc. (NASDAQ: GSIT): Pure AI Play Transforming Semiconductor Memory Solutions for Efficient AI Processing

Published

on

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12.

GSI Technology, Inc. (NASDAQ: GSIT) has witnessed a significant surge in its stock price, from $1.62 to $3.84, at the time of writing on Friday, May 12. This represents an impressive 137% increase; the volume has been off the hook. If you look at their historical chart, $GSIT had meager volume, sometimes as low as 300 shares traded in a day. If you do the math, that’s less than $500 worth of shares traded in a day – safe to say it was virtually illiquid.

So what happened, and what drove the stock to trade 50M shares with filings or news releases?

After an in-depth examination, GSI Technology, Inc. appears to have experienced a notable turning point in its market trajectory. The catalyst for this transformation was the company’s prominent feature on Fox News, triggering an exponential dissemination of information across various platforms. It is worth highlighting an intriguing phenomenon that tends to transpire in such circumstances: purchasing shares often induces a ripple effect, encouraging further buying activity.

With Fox News bringing the company into the spotlight and stimulating investor interest, a domino effect occurred among astute day traders who eagerly seized the opportunity to partake in this promising venture. Consequently, the trading volume for GSI Technology, Inc. skyrocketed to unprecedented levels, surpassing all previously recorded thresholds.

This surge in volume stands as a testament to the immense enthusiasm that enveloped the market as traders recognized the tremendous potential inherent in $GSIT. This collective enthusiasm resulted in an extraordinary demonstration of market engagement, reflecting a widespread acknowledgment of the company’s significance and the opportunities it presents.

https://twitter.com/SamanthaLaDuc/status/1657033207412293634?s=20

This development showcases the power of influential media coverage and underscores the intriguing dynamics that can arise when investor sentiment aligns with a compelling market narrative.

To Discover the Inside Scoop on GSIT, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Founded in 1995, GSI Technology Inc. has established itself as a prominent provider of semiconductor memory solutions. The company is focused on introducing new products that capitalize on its core strengths, which include radiation-hardened memory products for extreme environments and Gemini, an advanced processing unit (APU) designed to enhance performance in various artificial intelligence (AI) applications. Headquartered in Sunnyvale, California, GSI Technology operates sales offices in the Americas, Europe, and Asia.

GSI Technology is on the verge of reporting its earnings next week, and the company operates in the storage business, which supports the development of highly efficient AI chips. Traditionally, computing involves separate chips for storage and computation, necessitating frequent data exchange. This process incurs significant power consumption and presents scalability challenges.

To address these limitations, GSI Technology has developed a groundbreaking solution called In-memory processing. This innovation substantially reduces computation time from minutes to seconds, milliseconds, or even microseconds. Notably, it also significantly diminishes power consumption and overall cost of ownership. The key to this improvement lies in the massive parallel data processing offered by GSI’s technology, featuring two million-bit processors per chip compared to thousands found in standard graphic processing units (GPUs). Consequently, the system becomes more scalable, enabling efficient and accelerated AI processing.

By streamlining the computing process and integrating storage and computation on a single chip, GSI Technology aims to revolutionize AI processing. This approach offers notable benefits regarding power efficiency, computational speed, and scalability, making it an attractive solution for a wide range of AI applications.

In conclusion, GSI Technology, Inc. is poised to deliver innovative semiconductor memory solutions emphasizing AI chip development. The company aims to reduce computation time, power consumption, and total ownership cost through its In-memory processing technology while significantly improving scalability. With its upcoming earnings report, investors and industry observers will closely watch the company’s progress in the storage business and AI chip development.

We will update you on GSIT when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening with GSIT.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gerd Altmann from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.